McKesson (MCK) Tops Q2 EPS Views; Approves New $2B Buyback Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
McKesson Reports Fiscal 2016 Second-Quarter Results
October 29, 2015 7:30 AM EDTRevenues of $48.8 billion for the second quarter, up 10%. Second-quarter GAAP earnings per diluted share from continuing operations of $2.65, up 29%. Second-quarter Adjusted Earnings per diluted share of $3.31, up 19%. Consolidated results include a pre-tax gain of $51 million, or 14 cents per diluted share, from the sale of our ZEE Medical business. Board of Directors authorized a new $2 billion share repurchase program. Fiscal 2016 Outlook: Adjusted Earnings per diluted share of $12.50 to $13.00.
SAN... More



